Masimo (MASI) Total Non-Current Liabilities (2010 - 2026)

Masimo's (MASI) quarterly Total Non-Current Liabilities came in at $771.5 million in Q2 2026, down 39.41% year-on-year from $1.3 billion in Q2 2025, and down 13.3% quarter-over-quarter from $889.9 million in Q1 2026.

Masimo (MASI) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Masimo's Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $771.5 million for Q2 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 39.41% year-over-year to $771.5 million in Q2 2026; TTM through Apr 2026 was $771.5 million, a 39.41% decrease from a year earlier, with the FY2026 full-year figure at $889.9 million, down 40.79% from the prior year.
  • Total Non-Current Liabilities declined to $771.5 million in Q2 2026 per MASI's latest filing, from $889.9 million in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $1.7 billion in Q4 2022 and bottomed at $254.3 million in Q2 2022.
  • The 5-year median for Total Non-Current Liabilities is $1.5 billion (2022), against an average of $1.3 billion.
  • Across the five-year window, Total Non-Current Liabilities surged 635.1% in 2022 and plunged 40.79% in 2026, its largest moves.
  • Year by year, Total Non-Current Liabilities stood at $1.7 billion in 2022, then declined by 10.83% to $1.5 billion in 2023, then fell by 2.86% to $1.5 billion in 2024, then plunged by 38.19% to $928.9 million in 2025, then fell by 16.94% to $771.5 million in 2026.
  • Per Business Quant, the three latest MASI Total Non-Current Liabilities figures stand at $771.5 million (Q2 2026), $889.9 million (Q1 2026), and $928.9 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 201.40 Bn 194.75 Bn 6.27 Bn -
2 Stryker 122.29 Bn 119.41 Bn 3.81 Bn 20.94 Bn
3 Medtronic 105.01 Bn 96.40 Bn 6.41 Bn 41.44 Bn
4 Boston Scientific 64.81 Bn 63.59 Bn 3.61 Bn 41.88 Bn
5 Edwards Lifesciences 55.28 Bn 51.60 Bn 1.29 Bn 2.64 Bn
6 Dexcom 29.06 Bn 27.94 Bn 750.30 Mn 3.53 Bn
7 Koninklijke Philips 29.02 Bn 25.93 Bn 2.07 Bn 9.85 Bn
8 GE HealthCare Technologies 28.27 Bn 26.20 Bn 1.98 Bn 24.21 Bn
9 Smith & Nephew 25.80 Bn 25.22 Bn - 3.57 Bn
10 Masimo 9.39 Bn 9.27 Bn 250.80 Mn 771.50 Mn

Historic Data

Download Data
DateValue
Apr 4, 2026 771.50 Mn
Jan 3, 2026 889.90 Mn
Sep 27, 2025 928.90 Mn
Jun 28, 2025 1.28 Bn
Mar 29, 2025 1.27 Bn
Dec 28, 2024 1.50 Bn
Sep 28, 2024 1.48 Bn
Jun 29, 2024 1.39 Bn
Mar 30, 2024 1.45 Bn
Dec 30, 2023 1.55 Bn
Sep 30, 2023 1.60 Bn
Jul 1, 2023 1.58 Bn
Apr 1, 2023 1.65 Bn
Dec 31, 2022 1.74 Bn
Oct 1, 2022 1.68 Bn
Jul 2, 2022 1.47 Bn
Apr 2, 2022 254.31 Mn
Jan 1, 2022 272.80 Mn
Oct 2, 2021 228.25 Mn
Jul 3, 2021 220.03 Mn